DOI: 10.13140/RG.2.1.2422.6164
Abstract
To evaluate the legal application of ranibizumab for the treatment of Age-Related Macular Degeneration. Considering the clinical case informed, the indication of the medicine is corroborated by the available evidence.
Adicionar Comentário